BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24995122)

  • 1. Clinical potentials of human pluripotent stem cells in lung diseases.
    Quan Y; Wang D
    Clin Transl Med; 2014; 3():15. PubMed ID: 24995122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells.
    Wetsel RA; Wang D; Calame DG
    Annu Rev Med; 2011; 62():95-105. PubMed ID: 21226612
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wen B; Li E; Ustiyan V; Wang G; Guo M; Na CL; Kalin GT; Galvan V; Xu Y; Weaver TE; Kalin TV; Whitsett JA; Kalinichenko VV
    Am J Respir Crit Care Med; 2021 Feb; 203(4):471-483. PubMed ID: 32877203
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical therapy using iPSCs: hopes and challenges.
    Lu X; Zhao T
    Genomics Proteomics Bioinformatics; 2013 Oct; 11(5):294-8. PubMed ID: 24060840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of pluripotent stem cells and their derivatives: current status and future perspectives.
    Pendse S; Vaidya A; Kale V
    Regen Med; 2022 Sep; 17(9):677-690. PubMed ID: 35703035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration.
    Yang YP; Hsiao YJ; Chang KJ; Foustine S; Ko YL; Tsai YC; Tai HY; Ko YC; Chiou SH; Lin TC; Chen SJ; Chien Y; Hwang DK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.
    Chao TH; Chen IC; Tseng SY; Li YH
    Acta Cardiol Sin; 2014 Sep; 30(5):365-74. PubMed ID: 27122813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
    Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells in companion animals: how can we move the field forward?
    Barrachina L; Arshaghi TE; O'Brien A; Ivanovska A; Barry F
    Front Vet Sci; 2023; 10():1176772. PubMed ID: 37180067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.
    Quattrocelli M; Thorrez L; Sampaolesi M
    Recent Pat Drug Deliv Formul; 2013 Apr; 7(1):18-28. PubMed ID: 22974171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPSC-Derived Airway Epithelial Cells: Progress, Promise, and Challenges.
    Yu F; Liu F; Liang X; Duan L; Li Q; Pan G; Ma C; Liu M; Li M; Wang P; Zhao X
    Stem Cells; 2023 Jan; 41(1):1-10. PubMed ID: 36190736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
    Csöbönyeiová M; Polák Š; Danišovič L
    Exp Biol Med (Maywood); 2015 May; 240(5):549-56. PubMed ID: 25595188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies.
    Mazzola M; Di Pasquale E
    Front Bioeng Biotechnol; 2020; 8():455. PubMed ID: 32528940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering.
    Liu Z; Zhou J; Wang H; Zhao M; Wang C
    Regen Med Res; 2013 Dec; 1(1):6. PubMed ID: 25984325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy - The Turning Point of Cell-Based Regenerative Medicine.
    Parsons XH
    Br Biotechnol J; 2013 Oct; 3(4):424-457. PubMed ID: 24926434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.
    Pushp P; Nogueira DES; Rodrigues CAV; Ferreira FC; Cabral JMS; Gupta MK
    Stem Cell Rev Rep; 2021 Jun; 17(3):748-776. PubMed ID: 33098306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability.
    Fu X; Xu Y
    Genome Med; 2012; 4(6):55. PubMed ID: 22741526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.